日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Immune checkpoint inhibitor-induced pure red cell aplasia: a nationwide retrospective case series and literature review

免疫检查点抑制剂诱发的纯红细胞再生障碍性贫血：一项全国性回顾性病例系列研究及文献综述

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06748-0
Bisiou, Sirivanh; Lobbes, Hervé; Palassin, Pascale; Allouchery, Marion; Comont, Thibault; Rivet, Valérian
代谢
红细胞
细胞生物学
贫血
免疫/内分泌
发表日期：2026
文献求助 收藏

Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: A case report

高浓度局部应用辣椒素引起的二度烧伤伴活动障碍：病例报告

期刊:Pain Practice
影响因子:2.7
doi:10.1111/papr.13175
Trin, Kilian; Perino, Justine; Allouchery, Marion; Géniaux, Hélène; Miremont, Ghada; Salvo, Francesco
发表日期：2023
文献求助 收藏

Safety of Immune Checkpoint Inhibitor Resumption after Interruption for Immune-Related Adverse Events, a Narrative Review

免疫检查点抑制剂治疗中断后恢复治疗的安全性：一项叙述性综述

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14040955
Allouchery, Marion; Beuvon, Clément; Pérault-Pochat, Marie-Christine; Roblot, Pascal; Puyade, Mathieu; Martin, Mickaël
Checkpoint
免疫/内分泌
发表日期：2022
文献求助 收藏

Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients

非转移性炎性乳腺癌患者诊断时的循环 PIK3CA 突变检测

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-021-02643-y
Violette Allouchery, Anne Perdrix, Céline Calbrix, Anca Berghian, Justine Lequesne, Maxime Fontanilles, Marianne Leheurteur, Pascaline Etancelin, Nasrin Sarafan-Vasseur, Frédéric Di Fiore, Florian Clatot
肿瘤
乳腺癌
发表日期：2021
文献求助 收藏

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

癌症患者因 ≥2 级免疫相关不良事件而停用免疫检查点抑制剂后再次使用免疫检查点抑制剂的安全性

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-001622
Allouchery, Marion; Lombard, Thomas; Martin, Mickael; Rouby, Franck; Sassier, Marion; Bertin, Celia; Atzenhoffer, Marina; Miremont-Salame, Ghada; Perault-Pochat, Marie-Christine; Puyade, Mathieu
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2020
文献求助 收藏

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

乳腺癌患者在芳香化酶抑制剂辅助治疗结束时及复发后循环ESR1突变情况

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-018-0968-0
Allouchery, Violette; Beaussire, Ludivine; Perdrix, Anne; Sefrioui, David; Augusto, Laetitia; Guillemet, Cécile; Sarafan-Vasseur, Nasrin; Di Fiore, Frédéric; Clatot, Florian
乳腺癌
肿瘤免疫
肿瘤
发表日期：2018
文献求助 收藏